Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Also known as: Metastatic Squamous cell carcinoma of head and neck / Metastatic Squamous Cell Carcinoma of the Head and Neck / Metastatic Squamous Cell Carcinoma of the Head or Neck / Metastatic Head and Neck Cancer / Head and Neck Cancer Metastatic / Metastatic Head-and-neck Squamous-cell Carcinoma / Metastatic Head and Neck Squamous Cell Carcinoma
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00002 | Cetuximab | An endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck. |
| DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
| DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |